Submitting in vitro data to WWARN

The WWARN In Vitro Group strategy is to identify the most relevant drug sensitivity assays to design.

*Required for each submitted dataset:*	*Optional for each submitted dataset:*
Unique sample or patient identifier (anonymised)	Patient age
Date of inclusion	Gender
Basic information on study site and protocol	Genotype(s) of molecular resistance markers
Date of sample collection, sample parasitemia
Experimental protocol conditions
In vitro raw data from each drug tested

Search form